Acute Complications of Stem Cell Transplant

Seminars in Oncology Nursing

Volumn 25, Issue 2, 2009, Pages 129-138

  Rimkus, Chris ^a  

^a NONE

Author keywords

engraftment syndrome; pulmonary fibrosis; sinusoidal obstructive syndrome; Stem cell transplant; thrombotic microangiopathic syndrome

Indexed keywords

ACUTE DISEASE; ARTICLE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; METHODOLOGY; MORTALITY; NURSING; NURSING ASSESSMENT; ONCOLOGY NURSING; POSTOPERATIVE CARE; RISK FACTOR; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ACUTE DISEASE; GRAFT VS HOST DISEASE; HUMANS; INFECTION CONTROL; NURSING ASSESSMENT; ONCOLOGIC NURSING; POSTOPERATIVE CARE; RISK FACTORS; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 65349111283     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2009.03.007     Document Type: Article

References (47)

1. Center for International Blood & Marrow Transplant Research. Progress Report January - December 2007. Available at: http://www.cibmtr.org/ABOUT/Annual_Report/DOCS/annual_report.pdf. (accessed Nov 6, 2008.).
2. Artz A.S., Pollyea D.A., Kocherginsky M., et al. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 954-964
3. Sorror M.I., Maris M.B., Storb R., et al. Hematopoietic cell transplant (HCT)-specific comorbidity index. Blood 106 (2005) 2912-2918
4. Niess D, Duffy KM. Basic concepts of transplant. In Ezzone S, ed. Hematopoietic stem cell transplant: a manual for nursing practice. Pittsburgh, PA: Oncology Nursing Society; pp 13-21.
5. Morandi P., Ruffinin P.A., Benvenuto G.M., et al. Cardiac toxicity of high dose chemotherapy. Bone Marrow Transplant 35 (2005) 323-334
6. Tiersten A., Wo J., Jacobson C., et al. Cardiac toxicity observed in association with high dose cyclophosphamide-based chemotherapy for metastatic breast cancer. Breast 13 (2004) 341-346
7. Fadol A. Management of acute decompensated heart failure in patients with cancer. Clin J Oncol Nurs 10 (2006) 731-736
8. Cavet J., Lennard A., Gascoigne A., et al. Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphocytic leukemia. Bone Marrow Transplant 25 (2000) 571-573
9. Snowdenm J.A., Hill G.R., Hunt P., et al. Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplant 26 (2000) 309-313
10. Fischer V.L., Barnes Y.J., and Nuss S.L. Pretransplant conditioning in adults and children: dose assurance with busulfan. Oncol Nurs Forum 33 (2006) E36-E43
11. Horn T.D., Beveridge R.A., Egorin M.J., et al. Observations and proposed mechanisms of N2N'N"-triethylene-thiophosphoramid (thiotepa)-induced hyperpigmentation. Arch Dermatol 125 (1989) 524-527
12. Rosman H.S., Lloyd B.M., Hayashi R.J., et al. Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplant. J Am Acad Dermatol 58 (2008) 575-578
13. Kerbusch T., de Kraker J., and Keizer H.J. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites. Bone Marrow Transplant 40 (2001) 41-62
14. Patel P.N. Methylene blue for the treatment of ifosphamide-induced encephalopathy. Ann Pharmacother 40 (2006) 299-303
15. Junglee D., Katrak A., Mohiuddin J., et al. Salivary amylase and pancreatic enzymes in serum after total body irradiation. Clin Chemistry 32 (1986) 609-610
16. McAdams W., and Burgunder R. Transplant course. In: Ezzone S. (Ed). Hematopoietic stem cell transplantation: a manual for nursing practice (2005), Oncology Nursing Society, Pittsburgh, PA 43-59
17. Parikh C.R., Sandmaier B.M., Storb R.F., et al. Acute renal failure after nonmyeloablative hematopoietic cell transplant. J Am Soc Nephrol 15 (2004) 1868-1876
18. Humphreys B.D., Soiffer R.J., and Magee C.C. Renal failure associated with caner and its treatment: an update. J Am Soc Nephrol 16 (2005) 151-161
19. Higman M.A., Port J.D., Beauchamp Jr. N.J., et al. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 26 (2000) 797-800
20. Hequet O., Dumontet A.E.I., Jaafari-Corbin G., et al. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 29 (2002) 544
21. Lilleby K., Garcia B., Gooley T., et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplant. Bone Marrow Transplant 37 (2006) 1031-1035
22. Papus A.S., Clark R.E., Martuscelli G., et al. A prospective randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplant. Bone Marrow Transplant 31 (2003) 705-712
23. Lagner S., Stager P., Schub N., et al. Palifermin reduces the incidence and severity of oral mucositis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 42 (2008) 275-279
24. Loerzel V.W., and Dow K.H. Cardiac toxicity related to cancer treatment. Clin J Oncol Nurs 7 (2003) 557-562
25. Crawford S.W. Critical care and respiratory failure. In: Thomas E.D., Blume K.G., and Forman S.J. (Eds). Hematopoietic cell transplantation (1999), Blackwell Science, Boston, MA 712-722
26. Keller C.A. Cardiopulmonary effects. In: Ezzone S. (Ed). Hematopoietic stem cell transplantation: a manual for nursing practice (2005), Oncology Nursing Society, Pittsburgh, PA 177-189
27. Wanko S.O., Broadwater G., Folz R.J., et al. Diffuse alveolar hemorrhage: retrospective review of clinical outcomes in allogeneic transplant recipients treated with aminocaproic acid. Biol Blood Marrow Transplant 12 (2006) 949-953
28. Latchford T., and Shelton B.K. Respiratory syncytial virus in blood and marrow transplant recipients. Clin J Oncol Nurs 7 (2003) 418-422
29. Avery R., Kalaycio M., and Pohlman B. Early vancomycin enterococcus bacteremia (VRE) bacteremia after allogeneic stem cell transplant is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 35 (2005) 497-499
30. Tomblyn M., Gordon L., Singhal S., et al. Rarity of toxigenic clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone Marrow Transplant 30 (2002) 517-519
31. Gorschluter M., Mey U., Strehl J., et al. Neutropenic enterocolitis in adults: systematic analysis of evidence of quality. Eur J Haematol 75 (2005) 1-13
32. Gobel B.H., and Peterson G.J. Sepsis and septic shock. In: Kaplan M. (Ed). Understanding and managing oncologic emergencies: a resource for nurses (2006), Oncology Nursing Society, Pittsburgh, PA 159-195
33. DeLeve L.D., Shulman H.M., and McDonald G.B. Toxic injury to hepatic sinusoids: sinusoidal obstructive syndrome (veno-occlusive disease). Semin Liver Dis 2 (2002) 27-42
34. Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther 23 (2006) 11-25
35. Akasheh M., Eastwood D., and Vesole D.H. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte colony stimulating factor (GCSF) versus granulocyte-macrophage colony stimulating factor (GMCSF). Bone Marrow Transplant 31 (2003) 113-116
36. Spitzer T.R. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27 (2001) 893-898
37. Barton-Burke M., Dwinell D.M., Kafkas L., et al. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant. Oncology 22 suppl 11 (2008) 31-40
38. Machado M., Moreb J., and Khan S.A. Five cases of permanent alopecia after various conditioning regimens commonly used in bone marrow transplant. Biol Blood Marrow Transplant 13 (2007) 50-51
39. Chegounchi M, Hanna MG, Neild GH. Progressive neurologic disease induced by tacrolimus in a renal transplant recipient: a case presentation. BMC Nephrol (online). Available at: http://www.biomedcentral.com/1471-2369/7/7. (accessed Oct 8, 2008).
40. Sigeal D., Keller A., and Xu W. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 13 (2007) 1369-1379
41. Ho V.T., Cutler C., Carter S., et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 571-575
42. Visser A.M., van Doornum G.J.J., Cornelissen J.J., et al. Severe amnesia due to HHV-6 encephalitis after allogeneic stem cell transplantation. Eur Neurol 54 (2005) 233-234
43. Hentich M., Oruzio D., Jager G., et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 128 (2004) 66-72
44. Jones R.B., Mathes S., Shpall B.J., et al. Acute lung injury following treatment after high-dose cyclophosphamide, cisplatin, carmustine: pharmacodynamic evaluation of carmustine. J Natl Cancer Inst 85 (1993) 640-647
45. Akasheh M.S., Frytes C.O., and Vesole D.H. Melphalan-associated lung toxicity following high-dose chemotherapy with hematopoietic stem cell transplant. Bone Marrow Transplant 26 (2000) 1107-1109
46. Shen Y.C., Chiu C.F., Chow K.C., et al. Fatal fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor-I, transforming growth factor-b1, and cyclooxygenase-2. Bone Marrow Transplant 34 (2004) 609-614
47. Federoff A. BK virus in hematopoietic stem cell transplantation recipients. Clin J Oncol Nurs 12 (2008) 895-900